TrialEuropean journal of nuclear medicine and molecular imaging2013

¹⁸F-FDG PET SUVmax as an indicator of histopathologic response after neoadjuvant chemotherapy in extremity osteosarcoma.

Chang-Bae Kong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.